Resultado narrado por "TJ Oberholzer" em Todas as categorias

How do you lead your organization with the most important people in mind? In Foundational Leadership, Robert Griggs highlights his journey from being a young entrepreneur to becoming the founder and president of Trinity Products. After the loss of his mother at an early age, Robert began work for a farmer when he was fifteen. Through this experience, he grew to understand what it meant to have a strong work ethic and be an effective leader.

During life, everyone experiences difficult struggles and pain. The relief from this pain can come when either we recognize that we are only human and make an appropriate change for the better or when another person helps us recognize it and encourages us to make that change. These two phenomena are called self-compassion and compassion and are great powers that people possess to make life better. They are the first steps to take toward a healing process that results in one being able to enjoy and share all the wondrous experiences that life has to offer.

How do you build the capacity for change in yourselves and your organizations? With examples of coaching programs from around the world, Building the Core Competencies of Change explains the techniques of coaching that build the competencies for growth and change; provides examples of organizations that catalyzed change with the use of strategic coaching programs; and outlines the coaching types, tools, and models used to build core competencies of change in individuals, teams, and whole organizations.

Never heard of a professional employment organization? Well, you’re not alone. Yet PEOs have been providing the single most valuable set of services to small business owners for decades, allowing them to do what they do bestserving their clients and selling their products or services. After all, the administrative burdens that are thrust upon today’s small business owner are immense; since 1980 there has been an increase of over 400 percent in employment related laws and regulations.

Discover how the nation’s largest senior living operator answered the call posed by the greatest public health crisis in 100 years with courage and resilience. CEO Cindy Baier shares a mesmerizing, behind-the-scenes look at how Brookdale Senior Living navigated the COVID-19 pandemic as she stood at the helm of a company with $3.5 billion of revenue in 2020. Woven together with her own personal accounts, Cindy highlights the broad symphony of voices and diverse cast of players who proved pivotal in helping save lives.

In these turbulent times, companies can be forced to pivot on a dime to meet new market challenges. But how do you know which move to make? How do you hit on the solution to what’s threatening your bottom line? Ali Davachi draws from his decades of experience turning around companies to detail his innovative and proven system to creating positive change. In addition, Davachi walks the listener through common obstacles that hold businesses back from effectively confronting new challenges—and shows them how to create meaningful transformation that’s both powerful and profitable.

An ode to paths and the journeys we take through nature, as told by a gifted writer who stopped driving and rediscovered the joys of traveling by foot.  

The entrepreneurial path is full of excitement and risk. The stakes are high, and while it may seem like the sky is the limit, there are no guarantees. Businesses are prone to steep financial and tax challenges. Failure to address these issues could lead to drained accounts, mountains of debt, and doors closing. Mitigating these risks and maximizing services that lead to smart business decisions have the potential to do more than help an entrepreneur sleep at night; they can lay out a solid direction for both the company and the entrepreneur. 

The drug development process in the United States has become so weighted down by a business-as-usual paradigm that an average of more than two billion dollars is spent to secure FDA approval for every new drug. Because the investment required is so extreme, drug development companies are understandably focused on discovering and developing drugs designed for large patient populations: diseases experienced by millions, such as high blood pressure, diabetes, or some of the more common cancers.